Clinical trial
Prophylaxis With Caspofungin in High-Risk Liver Transplantation
NCT00333645 · Grupo de Estudio de Infecciones en Transplantados, Other · Unknown status
Key facts
| NCT number | NCT00333645 |
|---|---|
| Title | Prophylaxis With Caspofungin in High-Risk Liver Transplantation |
| Official title | Prophylaxis With Caspofungin for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients |
| Lead sponsor | Grupo de Estudio de Infecciones en Transplantados, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Transplantation, Fungal Infection |
| Intervention type | Drug |
| Interventions | Caspofungin |
| Enrollment | 70 |
| Start date | Oct 1, 2003 |
| Completion | Mar 1, 2007 |
| First posted | Jun 6, 2006 |
| Last update posted | Apr 13, 2007 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: